A limitation of this study is lack of AD biomarker characterization on the full sample, precluding consideration of amyloid and tau in statistical analyses, which could aid in informing potential associations between AD neuropathology and APOE-dependent mechanisms underlying microstructural differences. The gene discussed is MAPT; the disease is Alzheimer disease.